Unknown

Dataset Information

0

Day 10 Post-Prescription Audit Optimizes Antibiotic Therapy in Patients with Bloodstream Infections.


ABSTRACT: This study aimed to investigate the clinical and organizational impact of an active re-evaluation (on day 10) of patients on antibiotic treatment diagnosed with bloodstream infections (BSIs). A prospective, single center, pre-post quasi-experimental study was performed. Patients were enrolled at the time of microbial BSI confirmation. In the pre-intervention phase (August 2014-August 2015), clinical status and antibiotic regimen were re-evaluated at day 3. In the intervention phase (January 2016-January 2017), clinical status and antibiotic regimen were re-evaluated at day 3 and day 10. Primary outcomes were rate of optimal therapy, duration of antibiotic therapy, length of hospitalization, and 30-day mortality. A total of 632 patients were enrolled (pre-intervention period, n = 303; intervention period, n = 329). Average duration of therapy reduced from 18.1 days (standard deviation (SD), 11.4) in the pre-intervention period to 16.8 days (SD, 12.7) in the intervention period (p < 0.001). Similarly, average length of hospitalization decreased from 24.1 days (SD, 20.8) to 20.6 days (SD, 17.7) (p = 0.001). No inter-group difference was found for the rate of 30-day mortality. In patients with BSI, re-evaluation of clinical status and antibiotic regimen at day 3 and 10 after microbiological diagnosis was correlated with a reduction in the duration of antibiotic therapy and hospital stay. The intervention is simple and has a low impact on overall costs.

SUBMITTER: Murri R 

PROVIDER: S-EPMC7459471 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Day 10 Post-Prescription Audit Optimizes Antibiotic Therapy in Patients with Bloodstream Infections.

Murri Rita R   Palazzolo Claudia C   Giovannenze Francesca F   Taccari Francesco F   Camici Marta M   Spanu Teresa T   Posteraro Brunella B   Sanguinetti Maurizio M   Cauda Roberto R   Fantoni Massimo M  

Antibiotics (Basel, Switzerland) 20200723 8


This study aimed to investigate the clinical and organizational impact of an active re-evaluation (on day 10) of patients on antibiotic treatment diagnosed with bloodstream infections (BSIs). A prospective, single center, pre-post quasi-experimental study was performed. Patients were enrolled at the time of microbial BSI confirmation. In the pre-intervention phase (August 2014-August 2015), clinical status and antibiotic regimen were re-evaluated at day 3. In the intervention phase (January 2016  ...[more]

Similar Datasets

| S-EPMC7320076 | biostudies-literature
| S-EPMC4408103 | biostudies-literature
| S-EPMC5855174 | biostudies-literature
| S-EPMC9989898 | biostudies-literature
| S-EPMC9596539 | biostudies-literature
| S-EPMC5451052 | biostudies-literature
| S-EPMC8116419 | biostudies-literature
| S-EPMC10031584 | biostudies-literature
| S-EPMC6593441 | biostudies-literature